(Q33607509)

28 July 2017

1 reference

title

Biology of IL-5 in health and disease (English)

1 reference

28 July 2017

Lalani T

1

1 reference

PubMed ID

10227331

28 July 2017

Simmons RK

series ordinal

2

1 reference

PubMed ID

10227331

28 July 2017

Ahmed AR

series ordinal

3

1 reference

28 July 2017

1 April 1999

1 reference

Annals of Allergy, Asthma & Immunology

28 July 2017

1 reference

28 July 2017

82

1 reference

28 July 2017

4

1 reference

28 July 2017

317-32; quiz 332-3

1 reference

28 July 2017

Asthma and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Identification of a lymphokine that stimulates eosinophil differentiation in vitro. Its relationship to interleukin 3, and functional properties of eosinophils produced in cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

The biology of interleukin-5 and its receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Structure of recombinant human interleukin 5 produced by Chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

A novel dimer configuration revealed by the crystal structure at 2.4 A resolution of human interleukin-5

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Analysis of three human interleukin 5 structures suggests a possible receptor binding mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Mutated interleukin-5 monomers are biologically inactive

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Role of the C-terminus in the biological activity of human interleukin 5

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Recombinant human interleukin 5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assays

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor II.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Characterization of the human IL-5 receptors on eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Cytokine receptors and signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Critical cytoplasmic domains of the common beta subunit of the human GM-CSF, IL-3 and IL-5 receptors for growth signal transduction and tyrosine phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Cloning of cDNA for human T-cell replacing factor (interleukin-5) and comparison with the murine homologue

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin 5)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

New directions in understanding interleukin-5 gene expression.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Characterization of the mouse granulocyte-macrophage colony-stimulating factor (GM-CSF) gene promoter: nuclear factors that interact with an element shared by three lymphokine genes--those for GM-CSF, interleukin-4 (IL-4), and IL-5.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Interleukin-5 mRNA stability in human T cells is regulated differently than interleukin-2, interleukin-3, interleukin-4, granulocyte/macrophage colony-stimulating factor, and interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Identification of a Cys motif in the common beta chain of the interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 receptors essential for disulfide-linked receptor heterodimerization and activation of all three recepto

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

The activation of the JAK2/STAT5 pathway is commonly involved in signaling through the human IL-5 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Granulocyte-macrophage colony-stimulating factor and IL-5 activate mitogen-activated protein kinase through Jak2 kinase and phosphatidylinositol 3-kinase in human eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Interleukin 5 signals through Shc and Grb2 in human eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

The intracellular signal transduction mechanism of interleukin 5 in eosinophils: the involvement of lyn tyrosine kinase and the Ras-Raf-1-MEK-microtubule-associated protein kinase pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

A functional bipartite nuclear localisation signal in the cytokine interleukin-5.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Molecular Events Mediating T Cell Activation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Hodgkin's disease: a cytokine-producing tumor--a review

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Expression of interleukin-5 by human bone marrow microvascular endothelial cells: implications for the regulation of eosinophilopoiesis in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Allergen-specific human T cell clones produce interleukin-5 upon stimulation with the Th1 cytokine interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levels

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Recombinant interferon gamma therapy for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Eosinophilic pustular folliculitis effectively treated with recombinant interferon-gamma: suppression of mRNA expression of interleukin 5 in peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Interleukin-12 inhibits production of interleukin-5 but not of granulocyte/macrophage colony-stimulating factor by antigen-stimulated blood mononuclear cells in allergic bronchial asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Transforming growth factor beta abrogates the effects of hematopoietins on eosinophils and induces their apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Prostaglandin E2 differentially modulates IL-5 gene expression in activated human T lymphocytes depending on the costimulatory signal

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

The biological role of interleukin 5.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Biology of interleukin-5 and its relevance to allergic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Allergen-induced changes in bone marrow progenitors and airway responsiveness in dogs and the effect of inhaled budesonide on these parameters

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Interleukin-5 binds to heparin/heparan sulfate. A model for an interaction with extracellular matrix

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Recombinant human interleukin 5 is a selective eosinophil chemoattractant

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Murine eosinophil differentiation factor. An eosinophil-specific colony-stimulating factor with activity for human cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Respiratory burst of normal human eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Enhancement of human basophil histamine release by interleukin 5

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Expression and function of the Fas receptor on human blood and tissue eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

The eosinophilic leukocyte: structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Human interleukin-5 induces staphylococcal A Cowan 1 strain-activated human B cells to secrete IgM

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Interleukin 5 and interleukin 2 cooperate with interleukin 4 to induce IgG1 secretion from anti-Ig-treated B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Combinations of interleukins 2, 4 and 5 regulate the secretion of murine immunoglobulin isotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Induction of antibody synthesis by CD4+ T cells: IL 5 is essential for induction of antigen-specific antibody responses by TH2 but not TH1 clones

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Interleukin 5 (IL-5) provides a signal that is required in addition to IL-4 for isotype switching to immunoglobulin (Ig) G1 and IgE

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Human lung mast cell IL-5 gene and protein expression: temporal analysis of upregulation following IgE-mediated activation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Juvenile Diabetes Mellitus and Atopy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Regulation of disease susceptibility: decreased prevalence of IgE-mediated allergic disease in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Onchocerciasis and immunity in humans: enhanced T cell responsiveness to parasite antigen in putatively immune individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Eosinophilia and intracranial worm recovery in interleukin-5 transgenic and interleukin-5 receptor alpha chain-knockout mice infected with Angiostrongylus cantonensis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Eosinophils are the major effector cells of immunity to microfilariae in a mouse model of onchocerciasis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Strongyloides stercoralis: eosinophil-dependent immune-mediated killing of third stage larvae in BALB/cByJ mice

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Ablation of eosinophils with anti-IL-5 antibody enhances the survival of intracranial worms of Angiostrongylus cantonensis in the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Antibody to interleukin 5 prevents blood and tissue eosinophilia but not liver trapping in murine larval toxocariasis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Regulation and biological function of helminth-induced cytokine responses

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Cytokines in the peritoneal fluid of patients with endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

In vitro anti-tumor activity of eosinophils from cancer patients treated with subcutaneous administration of interleukin 2. Role of interleukin 5

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Tumour-associated eosinophilia: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Malignant tumor and eosinophils. I. Prognostic significance in gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Evidence that eosinophil infiltration in the OK-432/fibrinogen-injected Meth-A tumor in mice is mediated by locally produced IL-5

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

The role of eosinophils in the pathobiology of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis, and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Identification of thyroid stimulating hormone receptor-specific T cells in Graves' disease thyroid using autoantigen-transfected Epstein-Barr virus-transformed B cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Increased serum concentration of interleukin-5 in patients with Graves' disease and Hashimoto's thyroiditis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Confocal laser scanning microscopic and immunoelectron microscopic studies of the anatomical distribution of fibrillar IgA deposits in dermatitis herpetiformis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Electron microscopic study of dermatitis herpetiformis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

T lymphocytes in lesional skin of patients with dermatitis herpetiformis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Th2-like cytokine activity in dermatitis herpetiformis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Bullous pemphigoid: A cause of peripheral blood eosinophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Increased immunoreactive interleukin-5 levels in blister fluids of bullous pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Eosinophils, bronchial hyperreactivity and late-phase asthmatic reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

IL-4- and IL-5-positive T lymphocytes, eosinophils, and mast cells in allergen-induced late-phase cutaneous reactions in atopic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine B-cell stimulatory factor 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Eosinophil infiltration precedes development of airway hyperreactivity and mucosal exudation after intranasal administration of interleukin-5 to mice

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Effects of an antibody to interleukin-5 in a monkey model of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Clinical significance of measuring levels of sputum and serum ECP and serum IL-5 in bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Airways inflammation in nocturnal asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Nasal polyps--a model of chronic respiratory mucosal inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

IL-5 synthesis is upregulated in human nasal polyp tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Interleukin-5 Messenger RNA and Immunoreactive Protein Expression by Activated Eosinophils in Lesional Atopic Dermatitis Skin

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Correlation of house dust mite-specific lymphocyte proliferation with IL-5 production, eosinophilia, and the severity of symptoms in infants with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Effects of rapamycin, cyclosporin A, and dexamethasone on interleukin 5-induced eosinophil degranulation and prolonged survival

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

The mechanism of action of cyclosporin A and FK506

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Cyclosporin A and FK506 reduce interleukin-5 mRNA abundance by inhibiting gene transcription

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-gamma cytokine gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Inhibition of in vitro proliferative response of cultured T lymphocytes to interleukin-2 by gold sodium thiomalate

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Suppression of interleukin-2 and interleukin-2 receptor biosynthesis by gold compounds in in vitro activated human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Gold sodium thiomalate selectivity inhibits interleukin-5-mediated eosinophil survival.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Bronchial reactivities to acetylcholine and IgE levels in asthmatic subjects after long-term remissions.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Inhibitory effect of F-1322 on allergic eosinophil infiltration in airways

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Engineering Antibodies for Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Inhibition of pulmonary eosinophilia and hyperreactivity by antibodies to interleukin-5.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Inhibition of interleukin-5 with a monoclonal antibody attenuates allergic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Direct measurement of cytokines (IFN-gamma, IL-4, -5, and -6) from organs after antigenic challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Defining protective responses to pathogens: cytokine profiles in leprosy lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Histamine increases anti-CD3 induced IL-5 production of TH2-type T cells via histamine H2-receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

Inhibitory effect of cetirizine on cytokine-enhanced in vitro eosinophil survival.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963281-4

7 January 2021

10.1016/S1081-1206(10)63281-4

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10227331